1:00 - 1:05 PM | Welcome |
Ruta Waghmare, PhD Global Director, Market Sales Development, MilliporeSigma | |
1:05 - 1:30 PM | Overview of MilliporeSigma, the Life Science Business of Merck KGaA, Darmstadt, Germany How MilliporeSigma Supports the Journey of a Molecule |
Udit Batra, Member of the Executive Board, Merck KGaA, Darmstadt, Germany and CEO of MilliporeSigma |
1:30 - 2:30 PM | Industry Leader Panel Discussion: Concept to Clinic Success Stories |
Victor Perlroth, M.D., Chairman and Chief Executive Officer, Kodiak Sciences Tamas Blandl, Head of Biologics, Medivation, Inc. Douglas Crawford, Managing Director, Mission Bay Capital Moderator – Mike Trasatti, Head of Pharma Processing, Americas, MilliporeSigma |
2:30 - 3:00 PM | Break |
3:00 - 4:00 PM | Managing Investment in Process Development |
Martha S. Rook, Ph.D., Head of Gene Editing & Novel Modalities, MilliporeSigma Dr. Carlos Ibanez, Vice President, Product Development and Manufacturing, Tocagen Moderator – Thierry Cournez, Vice President E2E Processing Solutions, MilliporeSigma Serdar Alpan, Ph.D., Head of Biotechnology Group, TURGUT İlaçları A.Ş. |
4:00 - 5:00 PM | Fueling your vision |
Roel Bulthuis, Managing Director of Merck Ventures, BV Amsterdam, The Netherlands Ryan Bethencourt, Program Director and Venture Partner, IndieBio Alex Kopelyan, Program Manager, IndieBio Andreas Jurgeit, Ph.D., Director of Merck Ventures, BV Amsterdam, The Netherlands |
5:00 - 5:30 PM | Closing Remarks |
Jason Apter, Head of Research Solutions Strategic Marketing & Innovation, MilliporeSigma |
5:30 - 9:00 PM | Dinner at the Hotel |
Udit Batra, Member of the Executive Board, Merck KGaA, Darmstadt, Germany and CEO of MilliporeSigma will open the Summit.